Global /South Korea /Technology /Software - Application /380550

NEUROPHET, Inc.

380550

• KRX: 380550 • Delayed

20,100KRW -2.9%

13.16 USD

As of 10 June 2026, NEUROPHET, Inc. has a market cap of $163.91M USD, ranking #22316 globally and #932 in South Korea. It ranks #3288 in the Technology sector, and #956 in the Software - Application industry.

Global Rank

22316

Country Rank

932

Sector Rank

3288

Industry Rank

956

Key Stats

Market Cap

$163.91MUSD

250.3B KRW

Enterprise Value

$151.97MUSD

232.06B KRW

Revenue (TTM)

$1.71MUSD

2.62B KRW

EBITDA (TTM)

-$10.11MUSD

-15.44B KRW

Net Income (TTM)

-$14.66MUSD

-22.39B KRW

PS Ratio

95.7

PB Ratio

12.9

Company Profile

Country (HQ)

South Korea

Sector

Technology

Industry

Software - Application

Founded

2016

Website

neurophet.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.9%	-2.8%	-2.6%	-5%	3%	-7%	-56%	-56%	-56%

Upcoming Earnings

Earnings Date

Thu, Jun 18

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	380550 ISIN: KR7380550004 Shares Out.: Shares Outstanding: 12.199M¹ Shares Float: 7.707M² TV: TradingView: KRX: 380550 SA: Stock Analysis: KRX: 380550 YF: Yahoo Finance: 380550.KS GF: Google Finance: KRX: 380550 BA: Barron's: 380550 MS: Morningstar: XKRX: 380550	20,100 KRW	TV: TradingView: KRX: 380550 SA: Stock Analysis: KRX: 380550 YF: Yahoo Finance: 380550.KS GF: Google Finance: KRX: 380550 BA: Barron's: 380550 MS: Morningstar: XKRX: 380550

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About NEUROPHET, Inc.

Neurophet, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases. The company offers Neurophet AQUA, AI-powered diagnosis assistant software for brain diseases; Neurophet SCALE PET, a software that quantitatively analyzes biomarkers targeted by a specific radiotracer using PET; Neurophet tES LAB, AI-Powered software to generate a 3D model using brain MRI and simulate electrical stimulation for treatment planning; and Neurophet innk, a non-invasive electrical stimulation device designed to aid in the functional recovery and rehabilitation of patients with brain diseases. It also provides Consulting services for design systems and quality management systems. The company was founded in 2016 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Software - Application (South Korea)

Name	Market Cap (USD) diff.	PE	Country
NAVER Corp. KRX: 035420	$21.55B 32.91T KRW 13K%	17.0	South Korea
KRAFTON, Inc. KRX: 259960	$8.11B 12.39T KRW 5K%	17.0	South Korea
NC Corp. KRX: 036570	$3.52B 5.38T KRW 2K%	15.5	South Korea
Netmarble Corp. KRX: 251270	$2.53B 3.87T KRW 1K%	18.6	South Korea
Pearl Abyss Corp. KRX: 263750	$2.41B 3.68T KRW 1K%	-	South Korea
Douzone Bizon Co., Ltd. KRX: 012510	$2.2B 3.36T KRW 1K%	38.7	South Korea

Industry: Software - Application (Global)

Name	Market Cap (USD) diff.	PE	Country
Alphabet Inc. NASDAQ: GOOG	$4.23T 3M%	32.0	United States
Microsoft Corp. NASDAQ: MSFT	$3.15T 2M%	26.6	United States
Meta Platforms, Inc. NASDAQ: META	$1.7T 1M%	28.5	United States
Tencent Holdings Ltd. SHEK: 700	$551.55B 4.32T HKD 336K%	17.8	China
Oracle Corp. NYSE: ORCL	$471.18B 287K%	29.4	United States
Netflix, Inc. NASDAQ: NFLX	$387.9B 237K%	29.8	United States

chevron_leftBack